Literature DB >> 28595995

miR-146b Probably Assists miRNA-146a in the Suppression of Keratinocyte Proliferation and Inflammatory Responses in Psoriasis.

Helen Hermann1, Toomas Runnel2, Alar Aab1, Hansjörg Baurecht3, Elke Rodriguez3, Nathaniel Magilnick4, Egon Urgard1, Liisi Šahmatova5, Ele Prans6, Julia Maslovskaja1, Kristi Abram7, Maire Karelson7, Bret Kaldvee5, Paula Reemann1, Uku Haljasorg1, Beate Rückert8, Paulina Wawrzyniak8, Michael Weichenthal3, Ulrich Mrowietz3, Andre Franke9, Christian Gieger10, Jonathan Barker11, Richard Trembath12, Lam C Tsoi13, James T Elder14, Eric R Tkaczyk15, Kai Kisand1, Pärt Peterson1, Külli Kingo5, Mark Boldin4, Stephan Weidinger3, Cezmi A Akdis8, Ana Rebane16.   

Abstract

miR-146a inhibits inflammatory responses in human keratinocytes and in different mouse models of skin inflammation. Little is known about the role of miR-146b in the skin. In this study, we confirmed the increased expression of miR-146a and miR-146b (miR-146a/b) in the lesional skin of patients with psoriasis. The expression of miR-146a was approximately twofold higher than that of miR-146b in healthy human skin, and it was more strongly induced by stimulation of proinflammatory cytokines in keratinocytes and fibroblasts. miR-146a/b target genes regulating inflammatory responses or proliferation were altered in the skin of patients with psoriasis, among which FERMT1 was verified as a direct target of miR-146a. In silico analysis of genome-wide data from >4,000 psoriasis cases and >8,000 controls confirmed a moderate association between psoriasis and genetic variants in the miR-146a encoding gene. Transfection of miR-146a/b suppressed and inhibition enhanced keratinocyte proliferation and the expression of psoriasis-related target genes. Enhanced expression of miR-146a/b-influenced genes was detected in cultured keratinocytes from miR-146a-/- and skin fibroblasts from miR-146a-/- and miR-146b-/- mice stimulated with psoriasis-associated cytokines as compared with wild-type mice. Our results indicate that besides miR-146a, miR-146b is expressed and might be capable of modulation of inflammatory responses and keratinocyte proliferation in psoriatic skin.
Copyright © 2017 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28595995      PMCID: PMC5977389          DOI: 10.1016/j.jid.2017.05.012

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  36 in total

1.  Hiding under the skin: A welcome surprise in psoriasis.

Authors:  James G Krueger
Journal:  Nat Med       Date:  2012-12       Impact factor: 53.440

2.  NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses.

Authors:  Konstantin D Taganov; Mark P Boldin; Kuang-Jung Chang; David Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-02       Impact factor: 11.205

3.  Laser capture microdissection followed by next-generation sequencing identifies disease-related microRNAs in psoriatic skin that reflect systemic microRNA changes in psoriasis.

Authors:  Marianne B Løvendorf; Hiroshi Mitsui; John R Zibert; Mads A Røpke; Markus Hafner; Beatrice Dyring-Andersen; Charlotte M Bonefeld; James G Krueger; Lone Skov
Journal:  Exp Dermatol       Date:  2015-03       Impact factor: 3.960

4.  Secukinumab in plaque psoriasis--results of two phase 3 trials.

Authors:  Richard G Langley; Boni E Elewski; Mark Lebwohl; Kristian Reich; Christopher E M Griffiths; Kim Papp; Lluís Puig; Hidemi Nakagawa; Lynda Spelman; Bárður Sigurgeirsson; Enrique Rivas; Tsen-Fang Tsai; Norman Wasel; Stephen Tyring; Thomas Salko; Isabelle Hampele; Marianne Notter; Alexander Karpov; Silvia Helou; Charis Papavassilis
Journal:  N Engl J Med       Date:  2014-07-09       Impact factor: 91.245

5.  Pre-administration of PepFect6-microRNA-146a nanocomplexes inhibits inflammatory responses in keratinocytes and in a mouse model of irritant contact dermatitis.

Authors:  Egon Urgard; Annely Lorents; Mariliis Klaas; Kärt Padari; Janeli Viil; Toomas Runnel; Kent Langel; Külli Kingo; Eric Tkaczyk; Ülo Langel; Toivo Maimets; Viljar Jaks; Margus Pooga; Ana Rebane
Journal:  J Control Release       Date:  2016-06-03       Impact factor: 9.776

6.  Function of miR-146a in controlling Treg cell-mediated regulation of Th1 responses.

Authors:  Li-Fan Lu; Mark P Boldin; Ashutosh Chaudhry; Ling-Li Lin; Konstantin D Taganov; Toshikatsu Hanada; Akihiko Yoshimura; David Baltimore; Alexander Y Rudensky
Journal:  Cell       Date:  2010-09-17       Impact factor: 41.582

7.  Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity.

Authors:  Lam C Tsoi; Sarah L Spain; Jo Knight; Eva Ellinghaus; Philip E Stuart; Francesca Capon; Jun Ding; Yanming Li; Trilokraj Tejasvi; Johann E Gudjonsson; Hyun M Kang; Michael H Allen; Ross McManus; Giuseppe Novelli; Lena Samuelsson; Joost Schalkwijk; Mona Ståhle; A David Burden; Catherine H Smith; Michael J Cork; Xavier Estivill; Anne M Bowcock; Gerald G Krueger; Wolfgang Weger; Jane Worthington; Rachid Tazi-Ahnini; Frank O Nestle; Adrian Hayday; Per Hoffmann; Juliane Winkelmann; Cisca Wijmenga; Cordelia Langford; Sarah Edkins; Robert Andrews; Hannah Blackburn; Amy Strange; Gavin Band; Richard D Pearson; Damjan Vukcevic; Chris C A Spencer; Panos Deloukas; Ulrich Mrowietz; Stefan Schreiber; Stephan Weidinger; Sulev Koks; Külli Kingo; Tonu Esko; Andres Metspalu; Henry W Lim; John J Voorhees; Michael Weichenthal; H Erich Wichmann; Vinod Chandran; Cheryl F Rosen; Proton Rahman; Dafna D Gladman; Christopher E M Griffiths; Andre Reis; Juha Kere; Rajan P Nair; Andre Franke; Jonathan N W N Barker; Goncalo R Abecasis; James T Elder; Richard C Trembath
Journal:  Nat Genet       Date:  2012-11-11       Impact factor: 38.330

8.  A functional variant in microRNA-146a promoter modulates its expression and confers disease risk for systemic lupus erythematosus.

Authors:  Xiaobing Luo; Wanling Yang; Dong-Qing Ye; Huijuan Cui; Yan Zhang; Nattiya Hirankarn; Xiaoxia Qian; Yuanjia Tang; Yu Lung Lau; Niek de Vries; Paul Peter Tak; Betty P Tsao; Nan Shen
Journal:  PLoS Genet       Date:  2011-06-30       Impact factor: 5.917

9.  Meta-analysis of microRNA-146a rs2910164 G>C polymorphism association with autoimmune diseases susceptibility, an update based on 24 studies.

Authors:  Changzheng Li; Weijun Fu; Yu Zhang; Liang Zhou; Zhi Mao; Weiran Lv; Juan Li; Ye Zhou
Journal:  PLoS One       Date:  2015-04-01       Impact factor: 3.240

10.  Genome-wide comparative analysis of atopic dermatitis and psoriasis gives insight into opposing genetic mechanisms.

Authors:  Hansjörg Baurecht; Melanie Hotze; Stephan Brand; Carsten Büning; Paul Cormican; Aiden Corvin; David Ellinghaus; Eva Ellinghaus; Jorge Esparza-Gordillo; Regina Fölster-Holst; Andre Franke; Christian Gieger; Norbert Hubner; Thomas Illig; Alan D Irvine; Michael Kabesch; Young A E Lee; Wolfgang Lieb; Ingo Marenholz; W H Irwin McLean; Derek W Morris; Ulrich Mrowietz; Rajan Nair; Markus M Nöthen; Natalija Novak; Grainne M O'Regan; Stefan Schreiber; Catherine Smith; Konstantin Strauch; Philip E Stuart; Richard Trembath; Lam C Tsoi; Michael Weichenthal; Jonathan Barker; James T Elder; Stephan Weidinger; Heather J Cordell; Sara J Brown
Journal:  Am J Hum Genet       Date:  2015-01-08       Impact factor: 11.025

View more
  28 in total

1.  miR-10a-5p is increased in atopic dermatitis and has capacity to inhibit keratinocyte proliferation.

Authors:  Helen Vaher; Toomas Runnel; Egon Urgard; Alar Aab; Gemma Carreras Badosa; Julia Maslovskaja; Kristi Abram; Liisi Raam; Bret Kaldvee; Tarmo Annilo; Eric R Tkaczyk; Toivo Maimets; Cezmi A Akdis; Külli Kingo; Ana Rebane
Journal:  Allergy       Date:  2019-06-06       Impact factor: 13.146

2.  Identification of potential key molecules and signaling pathways for psoriasis based on weighted gene co-expression network analysis.

Authors:  Xin Shu; Xiao-Xia Chen; Xin-Dan Kang; Min Ran; You-Lin Wang; Zhen-Kai Zhao; Cheng-Xin Li
Journal:  World J Clin Cases       Date:  2022-06-26       Impact factor: 1.534

3.  Serum Levels of miR-146a in Patients with Psoriasis.

Authors:  Bárbara Leal; Cláudia Carvalho; Ana Marta Ferreira; Miguel Nogueira; Sandra Brás; Berta M Silva; Manuela Selores; Paulo P Costa; Tiago Torres
Journal:  Mol Diagn Ther       Date:  2021-05-02       Impact factor: 4.074

Review 4.  Molecular Mechanisms and Management of a Cutaneous Inflammatory Disorder: Psoriasis.

Authors:  Yu Ri Woo; Dae Ho Cho; Hyun Jeong Park
Journal:  Int J Mol Sci       Date:  2017-12-11       Impact factor: 5.923

5.  Combined Transcriptomic Analysis Revealed AKR1B10 Played an Important Role in Psoriasis through the Dysregulated Lipid Pathway and Overproliferation of Keratinocyte.

Authors:  Yunlu Gao; Xuemei Yi; Yangfeng Ding
Journal:  Biomed Res Int       Date:  2017-10-24       Impact factor: 3.411

Review 6.  Association of the Epithelial-Mesenchymal Transition (EMT) with Cisplatin Resistance.

Authors:  Milad Ashrafizadeh; Ali Zarrabi; Kiavash Hushmandi; Mahshad Kalantari; Reza Mohammadinejad; Tahereh Javaheri; Gautam Sethi
Journal:  Int J Mol Sci       Date:  2020-06-03       Impact factor: 5.923

Review 7.  Understanding psoriasis: Role of miRNAs.

Authors:  Teodora Larisa Timis; Remus Ioan Orasan
Journal:  Biomed Rep       Date:  2018-09-11

Review 8.  microRNAs involved in psoriasis and cardiovascular diseases.

Authors:  Sara Sileno; Sara Beji; Marco D'Agostino; Alessandra Carassiti; Guido Melillo; Alessandra Magenta
Journal:  Vasc Biol       Date:  2021-06-03

9.  Kochia scoparia Saponin Momordin Ic Modulates HaCaT Cell Proliferation and Apoptosis via the Wnt/β-Catenin Pathway.

Authors:  Meijunzi Luo; Bijun Zeng; Haizhen Wang; Zhibo Yang; Youhua Peng; Yujin Zhang; Chang Wang
Journal:  Evid Based Complement Alternat Med       Date:  2021-07-16       Impact factor: 2.629

10.  NAT2 Gene Polymorphisms in Turkish Patients with Psoriasis Vulgaris.

Authors:  Recep Dursun; Hatice Gül Dursun; Ayşe Gül Zamani; Mahmut Selman Yıldırım; İlknur Çınar
Journal:  Biomed Res Int       Date:  2018-06-11       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.